Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

• Status: Completed
• Trial end date: 2006-08-01

Summary

This study is to find out if Interferon-beta can recover its effectiveness in patients with Multiple Sclerosis who have previously developed neutralizing antibodies to Interferon-Beta.

• Phase: Phase 4

Details

• Lead Sponsor: Biogen
• Treatments: Antibodies; Immunoglobulins; Interferon beta-1a; Interferon-beta; Interferons; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate